Profilo
Mario Filion is the founder of Alethia Biotherapeutics, Inc. since 2002, holding the title of Chief Scientific Officer & Executive VP.
Former positions include Director-Molecular Genetics at Fortaleza Energy, Inc. and President-Clinical Genomics Division at SignalGene, Inc. Education includes a doctorate from the University of Montréal.
Posizioni attive di Mario Filion
| Società | Posizione | Inizio |
|---|---|---|
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Fondatore | 01/01/2002 |
Precedenti posizioni note di Mario Filion
| Società | Posizione | Fine |
|---|---|---|
| FORTALEZA ENERGY INC. | Corporate Officer/Principal | - |
SignalGene, Inc. | Corporate Officer/Principal | - |
Formazione di Mario Filion
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Fortaleza Energy, Inc.
Fortaleza Energy, Inc. Integrated OilEnergy Minerals Engages in the exploration, development and production of crude oil and natural gas | Energy Minerals |
University of Montréal
University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alethia Biotherapeutics, Inc.
Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets | Health Technology |
SignalGene, Inc. |
















